Epifriedelanol enhances adriamycin-induced cytotoxicity towards K562/ADM cells by down regulating of P-gp and MRP2

References

• Aleksunes LM, Klaassen CD. 2012. Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-null mice. Drug Metab Dispos. 40(7):1366–1379.
   PubMed Web of Science ®Google Scholar
• Chai X, Zeng S, Xie W. 2013. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin Drug Metab Toxicol. 9(3):253–266.
   PubMed Web of Science ®Google Scholar
• Chen T, Wang C, Liu Q, Meng Q, Sun H, Huo X, Sun P, Peng J, Liu Z, Yang X, et al. 2015. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway. Cancer Biol Ther. 16(1):106–114.
   PubMed Web of Science ®Google Scholar
• Chufan EE, Kapoor K, Ambudkar SV. 2016. Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Biochem Pharmacol. 101:40–53.
   PubMed Web of Science ®Google Scholar
• de Jonge-Peeters S, Kuipers F, de Vries EG, Vellenga E. 2007. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Crit Rev Oncol Hematol. 62(3):214–226.
   PubMed Web of Science ®Google Scholar
• Escherich G, Zimmermann M, Janka-Schaub G. 2013. Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. Pediatr Blood Cancer. 60(2):254–257.
   PubMed Web of Science ®Google Scholar
• Haferlach T, Schmidts I. 2020. The power and potential of integrated diagnostics in acute myeloid leukaemia. Br J Haematol. 188(1):36–48.
   PubMed Web of Science ®Google Scholar
• Hosny M, Zheng MS, Zhang H, Chang HW, Woo MH, Son JK, Lee SK. 2014. (-)-Catechin glycosides from Ulmus davidiana. Arch Pharm Res. 37(6):698–705.
   PubMed Web of Science ®Google Scholar
• Huang L, Huang M, Li YH, Li RM, Zeng Y, Kuang SY, Zhang L, Wang YT, Bi HC. 2013. Up-regulatation of CYP3A expression through pregnent X receptor by praeruptorin D isolated from Peucedanum praeruptorum Dunn. J Ethnopharmacol. 148(2):596–602.
   PubMed Web of Science ®Google Scholar
• Jung MJ, Heo SI, Wang MH. 2008. Free radical scavenging and total phenolic contents from methanolic extracts of Ulmus davidiana. Food Chem. 108(2):482–487.
   PubMed Web of Science ®Google Scholar
• Kantarjian HM, Keating MJ, Freireich EJ. 2018. Toward the potential cure of leukemias in the next decade. Cancer. 124(22):4301–4313.
   PubMed Web of Science ®Google Scholar
• Kim EH, Jo CS, Ryu SY, Kim SH, Lee JY. 2018. Anti-osteoclastogenic diacetylenic components of Dendropanax morbifera. Arch Pharm Res. 41(5):506–512.
   PubMed Web of Science ®Google Scholar
• Kim YC, Lee MK, Sung SH, Kim SH. 2007. Sesquiterpenes from Ulmus davidiana var. japonica with the inhibitory effects on lipopolysaccharide-induced nitric oxide production. Fitoterapia. 78(3):196–199.
   PubMed Web of Science ®Google Scholar
• Kundu JK, Rouf AS, Hossain MN, Hasan CM, Rashid MA. 2000. Antitumor activity of epifriedelanol from Vitis trifolia. Fitoterapia. 71(5):577–579.
   PubMedGoogle Scholar
• Lee GY, Jang DS, Kim J, Kim CS, Kim YS, Kim JH, Kim JS. 2008. Flavan-3-ols from Ulmus davidiana var. japonica with inhibitory activity on protein glycation. Planta Med. 74(15):1800–1802.
   PubMed Web of Science ®Google Scholar
• Lee JC, Lee KY, Son YO, Choi KC, Kim J, Truong TT, Jang YS. 2005. Plant-originated glycoprotein, G-120, inhibits the growth of MCF-7 cells and induces their apoptosis. Food Chem Toxicol. 43(6):961–968.
   PubMed Web of Science ®Google Scholar
• Lee MK, Sung SH, Lee HS, Cho JH, Kim YC. 2001. Lignan and neolignan glycosides from Ulmus davidiana var. japonica. Arch Pharm Res. 24(3):198–201.
   PubMed Web of Science ®Google Scholar
• Li Y, Huang L, Zeng X, Zhong G, Ying M, Huang M, Bi H. 2014. Down-regulation of P-gp expression and function after Mulberroside A treatment: potential role of protein kinase C and NF-kappa B. Chem Biol Interact. 213:44–50.
   PubMed Web of Science ®Google Scholar
• Li H, Hui L, Xu W, Shen H, Chen Q, Long L, Zhu X. 2012. Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells. Oncol Lett. 3(2):485–489.
   PubMed Web of Science ®Google Scholar
• Nabekura T, Hiroi T, Kawasaki T, Uwai Y. 2015. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. Biomed Pharmacother. 70:140–145.
   PubMed Web of Science ®Google Scholar
• Pan J, Miao D, Chen L. 2018. Germacrone reverses adriamycin resistance in human chronic myelogenous leukemia K562/ADM cells by suppressing MDR1 gene/P-glycoprotein expression. Chem Biol Interact. 288:32–37.
   PubMed Web of Science ®Google Scholar
• Ren J, Xu Y, Huang Q, Yang J, Yang M, Hu K, Wei K. 2015. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells. Anticancer Drugs. 26(5):498–507.
   PubMed Web of Science ®Google Scholar
• Rigalli JP, Tocchetti GN, Weiss J. 2019. Modulation of ABC Transporters by Nuclear Receptors: Physiological, Pathological and Pharmacological Aspects. Curr Med Chem. 26(7):1079–1112.
   PubMed Web of Science ®Google Scholar
• Saidijam M, Karimi Dermani F, Sohrabi S, Patching SG. 2018. Efflux proteins at the blood-brain barrier: review and bioinformatics analysis. Xenobiotica. 48(5):506–532.
   PubMed Web of Science ®Google Scholar
• Sengupta A, Banerjee D, Chandra S, Banerji SK, Ghosh R, Roy R, Banerjee S. 2007. Deregulation and cross talk among Sonic hedgehog, Wnt, Hox and Notch signaling in chronic myeloid leukemia progression. Leukemia. 21(5):949–955.
   PubMed Web of Science ®Google Scholar
• Shin DY, Kim HS, Min KH, Hyun SS, Kim SA, Huh H, Choi EC, Choi YH, Kim J, Choi SH, et al. 2000. Isolation of a potent anti-MRSA sesquiterpenoid quinone from Ulmus davidiana var. japonica. Chem Pharm Bull. 48(11):1805–1806.
   PubMed Web of Science ®Google Scholar
• Thompson PA, Kantarjian HM, Cortes JE. 2015. Diagnosis and treatment of chronic myeloid Leukemia in 2015. Mayo Clin Proc. 90(10):1440–1454.
   PubMed Web of Science ®Google Scholar
• Toyoda Y, Hagiya Y, Adachi T, Hoshijima K, Kuo MT, Ishikawa T. 2008. MRP class of human ATP binding cassette (ABC) transporters: historical background and new research directions. Xenobiotica. 38(7-8):833–862.
   PubMed Web of Science ®Google Scholar
• Umsumarng S, Pitchakarn P, Sastraruji K, Yodkeeree S, Ung AT, Pyne SG, Limtrakul P. 2015. Reversal of human multi-drug resistance leukaemic cells by stemofoline derivatives via inhibition of P-glycoprotein function. Basic Clin Pharmacol Toxicol. 116(5):390–397.
   PubMed Web of Science ®Google Scholar
• van der Kolk DM, de Vries EG, Müller M, Vellenga E. 2002. The role of drug efflux pumps in acute myeloid leukemia. Leuk Lymphoma. 43(4):685–701.
   PubMed Web of Science ®Google Scholar
• Whyte-Allman SK, Hoque MT, Jenabian MA, Routy JP, Bendayan R. 2017. Xenobiotic nuclear receptors pregnane X receptor and constitutive androstane receptor regulate antiretroviral drug efflux transporters at the blood-testis barrier. J Pharmacol Exp Ther. 363(3):324–335.
   PubMed Web of Science ®Google Scholar
• Yang HH, Son JK, Jung B, Zheng M, Kim JR. 2011. Epifriedelanol from the root bark of Ulmus davidiana inhibits cellular senescence in human primary cells. Planta Med. 77(5):441–449.
   PubMed Web of Science ®Google Scholar
• Yi YJ, Jia XH, Zhu C, Wang JY, Chen JR, Wang H, Li YJ. 2018. Solanine reverses multidrug resistance in human myelogenous leukemia K562/ADM cells by downregulating MRP1 expression. Oncol Lett. 15(6):10070–10076.
   PubMed Web of Science ®Google Scholar
• Zhou SF. 2008. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 38(7–8):802–832.
   PubMed Web of Science ®Google Scholar
• Zhou X, Ma X, Sun H, Li X, Cao H, Jiang Y, Wang P, Xie S, Li Y, Sun Y. 2020. Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cells. Leuk Lymphoma. 61(14):3451–3459.
   PubMed Web of Science ®Google Scholar